Active — Not RecruitingNot Applicable

Pancreas Cancer Surveillance Using an Abbreviated MRI

South Korea200 participantsStarted 2020-10-28

Plain-language summary

This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.

Who can participate

Age range50 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * On follow-up due to first degree-family history of PAC * Or on follow-up for BD-IPMN (\>= 2 cm) or main-duct type IPMN (\> 5 mm) * And signed informed consent Exclusion Criteria: * Contra-indication of performing MRI * Not satisfying the selection criteria. * Previously diagnosed with pancreatic malignancy * Pregnancy or planning pregnancy

What they're measuring

Detection of pancreas cancer

Timeframe: 1 year after the last surveillance MRI.

Trial details

NCT IDNCT04592393

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Pancreas Cancer trials